Boswellic Acids as Promising Leads in Drug Development against Alzheimer's Disease

• Principais autores: Hossein Haghaei (Autor), Somaieh Soltani (Autor), Seyedrafie Aref Hosseini (Autor), Mohammad Reza Rashidi (Autor), Saeed Karima (Autor)
• Formato: Livro
• Publicado em: Tabriz University of Medical Sciences, 2021-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Biological activity of Boswellia extract (BE) has been attributed to its main active ingredients; i.e. Boswellic acids (BAs). BE/BAs possess a promising therapeutic potential in neurodegenerative disorders; including Alzheimer's disease (AD). The multifactorial nature of AD pathophysiology nece...